Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of gabapentin adjunctive therapy in pediatric partial seizures
2014-004174-42Phase 3
- Sponsor
- Pfizer
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of gabapentin in epilepsy, sponsored by Pfizer. Primary endpoint: Response Ratio of Gabapentin in Japanese Paediatric Subjects With Partial Seizures.
02
Drugs
gabapentin
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2014-004174-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004174-42.